ImerysIMYSF -7.92%59 EBIT per Share is $-4.34 as of Dec. 2025. GuruFocus rates IMYSF with a GF Score™ of 59/100 and a GF Value™ of $30.30 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,339 Chemicals companies, Imerys ranks worse than 77.07% on this metric.
Imerys's EBIT per Share for the
six
months ended in Dec. 2025 was $-6.07.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $-4.34.
During the past 12 months, the average EBIT per Share Growth Rate of Imerys was -23.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -21.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -10.00% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -8.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Imerys's EBIT per Share or its related term are showing as below:
IMYSF'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -32.2 Med: -3.9 Max: 39
Current: -21.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Imerys was 39.00% per year. The lowest was -32.20% per year. And the median was -3.90% per year.
IMYSF's 3-Year EBIT Growth Rate is ranked worse than 77.07% of 1339
companies
in the Chemicals industry
Industry Median: -1.2
vs IMYSF: -21.60
Imerys's EBIT for the
six
months ended in Dec. 2025 was $-521 Mil.
Imerys (OTCPK:IMYSF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Imerys EBIT per Share Related Terms
Imerys EBIT per Share Historical Data
* Premium members only.
The historical data trend for Imerys's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-4.34
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Imerys (IMYSF) has a EBIT per Share of $-4.34 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Imerys and its competitors. According to the industry distribution chart, Imerys ranks #1032 out of 1339 companies in the Chemicals industry, placing it in the top 77.1%.
Is Imerys' EBIT per Share too high?
Imerys' current EBIT per Share is $-4.34. Based on the distribution chart, Imerys ranks #1032 out of 1339 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Imerys has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Imerys' EBIT per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Imerys ranks #1032 out of 1339 companies for EBIT per Share. This places Imerys in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Imerys and its competitors. Imerys's current EBIT per Share is $-4.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imerys stock overvalued right now?
Based on GuruFocus' analysis, Imerys (IMYSF) is currently considered Modestly Undervalued. The stock's GF Value™ is $30.30, compared to a current price of $24.91 — trading 17.8% below its estimated fair value. The current EBIT per Share is $-4.34. Imerys' overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Imerys (IMYSF), the current EBIT per Share is $-4.34 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Imerys (IMYSF) Overvalued in 2026?
Based on GuruFocus' analysis, Imerys stock appears to be undervalued.
The current stock price of $24.91 is trading 17.8% below its estimated GF Value™ of $30.30.
GuruFocus considers Imerys to be Modestly Undervalued.
Key valuation signals for IMYSF:
EBIT per Share: $-4.34
GF Value™: $30.30 vs. price of $24.91 (17.8% below fair value)
No single metric tells the full story. See the IMYSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Imerys manufactures and sells mineral-based specialty applications for multiple industries, including construction, renovation, iron and steel, and automotive. The company is organized into three activities: Performance Minerals comprises three geographic business areas - Europe, the Middle East and Africa, the Americas, and the Asia Pacific. It mainly serves the plastics, rubber, paints & coatings, filtration, renewable energy, and paper & board markets. The company operates in three segments: Performance Minerals, Refractory, Abrasives & Construction, and Solutions for Energy Transition. The majority of the revenue is generated from the Performance Minerals segment.
59GF Score
Get the complete analysis for IMYSF
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IMYSF has been successfully added to your 
